We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Two Doses Mesalazine Granules Versus Placebo for the Prevention of Recurrence of Diverticulitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01038739
Recruitment Status : Terminated (Stopped due to futility.)
First Posted : December 24, 2009
Last Update Posted : July 21, 2017
Information provided by (Responsible Party):
Dr. Falk Pharma GmbH